Reauthorization of MDUFA: What It Means for Jobs, Innovation and Patients

Wednesday, February 15, 2012 - 10:00am
2322 Rayburn
Background Documents and Information: 
Witnesses: 

Panel I

 

Dr. Jeffrey Shuren

Panel II

 

David Perez

Elisabeth M. George

Ralph Hall, J.D.

Ross Jaffe, M.D.

Aaron S. Kesselheim, M.D., J.D., M.P.H.

  • Assistant Professor of Medicine at Harvard Medical School
  • Division of Pharmacoepidemiology and Pharmacoeconomics
  • Brigham and Women's Hospital
  • Witness Testimony (Truth in Testimony)

Art Sedrakyan, M.D., Ph.D.

  • Associate Professor
  • Director, Patient-Centered Comparative Effectiveness Program
  • Weill Cornell Medical College and New York Presbyterian Hospital
  • Witness Testimony (Truth in Testimony)

Lisa Swirsky

Mr. Jim Shull

Congress: